CONTRACT PHARMACAL FDA Approval ANDA 074635

ANDA 074635

CONTRACT PHARMACAL

FDA Drug Application

Application #074635

Application Sponsors

ANDA 074635CONTRACT PHARMACAL

Marketing Status

Over-the-counter001

Application Products

001TABLET;ORAL220MG0NAPROXEN SODIUMNAPROXEN SODIUM

FDA Submissions

ORIG1AP1997-01-13
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1998-12-07
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1998-04-28
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1999-02-11
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1999-02-11
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2000-03-03
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2000-03-03
LABELING; LabelingSUPPL8AP1999-08-24
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2000-08-02
MANUF (CMC); Manufacturing (CMC)SUPPL12AP2000-09-21
MANUF (CMC); Manufacturing (CMC)SUPPL13AP2002-04-29
MANUF (CMC); Manufacturing (CMC)SUPPL14AP2002-04-29
MANUF (CMC); Manufacturing (CMC)SUPPL15AP2002-09-04
LABELING; LabelingSUPPL17AP2006-03-13

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL10Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0

CDER Filings

CONTRACT PHARMACAL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 74635
            [companyName] => CONTRACT PHARMACAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"NAPROXEN SODIUM","activeIngredients":"NAPROXEN SODIUM","strength":"220MG","dosageForm":"TABLET;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NAPROXEN SODIUM","submission":"NAPROXEN SODIUM","actionType":"220MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.